Compass Therapeutics (CMPX) Shares Outstanding (2023 - 2025)
Historic Shares Outstanding for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $177.6 million.
- Compass Therapeutics' Shares Outstanding rose 2905.97% to $177.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $177.6 million, marking a year-over-year increase of 2905.97%. This contributed to the annual value of $137.8 million for FY2024, which is 795.19% up from last year.
- According to the latest figures from Q3 2025, Compass Therapeutics' Shares Outstanding is $177.6 million, which was up 2905.97% from $138.3 million recorded in Q2 2025.
- Over the past 5 years, Compass Therapeutics' Shares Outstanding peaked at $177.6 million during Q3 2025, and registered a low of $126.4 million during Q1 2023.
- Its 3-year average for Shares Outstanding is $137.6 million, with a median of $137.6 million in 2024.
- The largest annual percentage gain for Compass Therapeutics' Shares Outstanding in the last 5 years was 2905.97% (2025), contrasted with its biggest fall of 50.37% (2025).
- Compass Therapeutics' Shares Outstanding (Quarter) stood at $127.7 million in 2023, then increased by 7.95% to $137.8 million in 2024, then grew by 28.84% to $177.6 million in 2025.
- Its Shares Outstanding was $177.6 million in Q3 2025, compared to $138.3 million in Q2 2025 and $138.3 million in Q1 2025.